|
|
Andre Bafica, Charles A. Scanga, Charles Serhan, Fabiana Machado, Sandy White, Alan Sher, Julio Aliberti
J Clin Invest. 2005;
115(6):1601
doi:10.1172/JCI23949
Abstract |
Full text
| PDF

T
h1 type cytokine responses are critical in the control of Mycobacterium tuberculosis infection. Recent findings indicate that 5-lipoxygenase–dependent (5-LO–dependent) lipoxins regulate host IL-12 production in vivo. Here, we establish lipoxins as key chemical mediators in resistance to M. tuberculosis infection. High levels of lipoxin A4 (LXA4) were detected in sera from infected WT but not infected 5-LO–deficient mice. Moreover, lungs from M. tuberculosis–infected 5-lo–/– animals showed increased IL-12, IFN-γ, and NO synthase 2 (NOS2) mRNA levels compared with the same tissues in WT mice. Similarly, splenocyte recall responses were enhanced in mycobacteria-infected 5-lo–/– versus WT mice. Importantly, bacterial burdens in 5-lo–/– lungs were significantly lower than those from WT mice, and this enhancement in the resistance of the 5-lo–/– animals to M. tuberculosis was completely prevented by administration of a stable LXA4 analog. Together our results demonstrate that lipoxins negatively regulate protective Th1 responses against mycobacterial infection in vivo and suggest that the inhibition of lipoxin biosynthesis could serve as a strategy for enhancing host resistance to M. tuberculosis.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(29)
| Title and authors |
Publication |
Year |
Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections
David M. Tobin, Francisco J. Roca, Sungwhan F. Oh, Ross McFarland, Thad W. Vickery, John P. Ray, Dennis C. Ko, Yuxia Zou, Nguyen D. Bang, Tran T.H. Chau
|
Cell
|
2012 |
Role of innate cytokines in mycobacterial infection
A M Cooper, K D Mayer-Barber, A Sher
|
Mucosal Immunol
|
2011 |
Association analysis of the LTA4H gene polymorphisms and pulmonary tuberculosis in 9115 subjects.
James Curtis, Liliya Kopanitsa, Emma Stebbings, Arran Speirs, Olga Ignatyeva, Yanina Balabanova, Vladyslav Nikolayevskyy, Sven Hoffner, Rolf Horstmann, Francis Drobniewski, Sergey Nejentsev
|
Tuberculosis (Edinb)
|
2011 |
Old and new generation lipid mediators in acute inflammation and resolution
Melanie J. Stables, Derek W. Gilroy
|
Progress in Lipid Research
|
2011 |
Two dimensional difference gel electrophoresis analysis of cerebrospinal fluid in tuberculous meningitis patients
Jitender Kataria, Lokesh A. Rukmangadachar, Gururao Hariprasad, Jithesh O, Manjari Tripathi, Alagiri Srinivasan
|
Journal of Proteomics
|
2011 |
Lipids, apoptosis, and cross-presentation: links in the chain of host defense against Mycobacterium tuberculosis
Samuel M. Behar, Constance J. Martin, Cláudio Nunes-Alves, Maziar Divangahi, Heinz G. Remold
|
Microbes and Infection
|
2011 |
Human genetic susceptibility to intracellular pathogens
Fredrik O. Vannberg, Stephen J. Chapman, Adrian V. S. Hill
|
Immunological Reviews
|
2011 |
Arachidonate 5-Lipoxygenase Establishes Adaptive Humoral Immunity by Controlling Primary B Cells and Their Cognate T-Cell Help
Tsutomu Nagashima, Shingo Ichimiya, Tomoki Kikuchi, Yoshiyuki Saito, Hiroshi Matsumiya, Shihoko Ara, Shigeru Koshiba, Jun Zhang, Chizuru Hatate, Akiko Tonooka, Terufumi Kubo, Rui Carrie Ye, Bungo Hirose, Hideaki Shirasaki, Takashi Izumi, Tsuyoshi Takami, Tetsuo Himi, Noriyuki Sato
|
The American Journal of Pathology
|
2011 |
Lipoxin A4 Increases Survival by Decreasing Systemic Inflammation and Bacterial Load in Sepsis :
Jean Walker, Eric Dichter, Grace Lacorte, David Kerner, Bernd Spur, Ana Rodriguez, Kingsley Yin
|
Shock
|
2011 |
Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis.
Maziar Divangahi, Danielle Desjardins, Cláudio Nunes-Alves, Heinz G Remold, Samuel M Behar
|
Nat Immunol
|
2010 |
|